Back
NovoCure Ltd. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
6
NVCR
NovoCure Ltd.
Last Price:
$12.55
Seasonality Move:
4.67%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVCR is experiencing buying pressure, which is a positive indicator for future bullish movement.
NovoCure Ltd. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.85 | Sell |
| 20-day SMA: | 12.3 | Sell |
| 50-day SMA: | 12.77 | Sell |
| 200-day SMA: | 14.07 | Sell |
| 8-day EMA: | 10.88 | Sell |
| 20-day EMA: | 11.85 | Sell |
| 50-day EMA: | 12.5 | Sell |
| 200-day EMA: | 14.27 | Sell |
NovoCure Ltd. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.81 | Sell |
| Relative Strength Index (14 RSI): | 31.55 | Sell |
| Chaikin Money Flow: | 2371086 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.24 - 14.16) | Sell |
| Bollinger Bands (100): | (11.71 - 13.95) | Sell |
NovoCure Ltd. Technical Analysis
| Jan 29 | Jan 30 | Feb 2 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 9 | Feb 10 | Feb 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | Feb | |||||||||
| 29 | 30 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for NovoCure Ltd. Stock
Is NovoCure Ltd. Stock a Buy?
-
NovoCure Ltd. share price is 10.50 while NVCR 8-day simple moving average is 10.85, which is a Sell signal.
-
The stock price of NVCR is 10.50 while NovoCure Ltd. 20-day SMA is 12.30, which makes it a Sell.
-
NovoCure Ltd. 50-day simple moving average is 12.77 while NVCR share price is 10.50, making it a Sell technically.
-
NVCR stock price is 10.50 and NovoCure Ltd. 200-day simple moving average is 14.07, creating a Sell signal.
NVCR Technical Analysis vs Fundamental Analysis
Sell
6
NovoCure Ltd. (NVCR)
is a Sell
Is NovoCure Ltd. a Buy or a Sell?
-
NovoCure Ltd. stock is rated a SellThe current NovoCure Ltd. [NVCR] share price is $10.50. The Score for NVCR is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
NovoCure Ltd. Stock Info
Market Cap:
1.2B
Price in USD:
10.50
Share Volume:
2.8M
NovoCure Ltd. 52-Week Range
52-Week High:
22.95
52-Week Low:
9.82
Sell
6
NovoCure Ltd. (NVCR)
is a Sell
NovoCure Ltd. Share Price Forecast
-
What is the NovoCure Ltd. stock price today?The NovoCure Ltd. stock price is 10.50 USD today.
-
Will NVCR stock go up or go down?NovoCure Ltd.> share price is forecast to RISE/FALL based on technical indicators
-
Is NovoCure Ltd. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, NovoCure Ltd. is overvalued.
Is NovoCure Ltd. Stock a Buy?
-
NovoCure Ltd. share price is 10.50 while NVCR 8-day exponential moving average is 10.88, which is a Sell signal.
-
The stock price of NVCR is 10.50 while NovoCure Ltd. 20-day EMA is 11.85, which makes it a Sell.
-
NovoCure Ltd. 50-day exponential moving average is 12.50 while NVCR share price is 10.50, making it a Sell technically.
-
NVCR stock price is 10.50 and NovoCure Ltd. 200-day simple moving average is 14.27, creating a Sell signal.
Fundamental Analysis of NovoCure Ltd.
Is NovoCure Ltd. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.16 per share, and an increase next year of $0.43 per share.
Technical Analysis of NovoCure Ltd.
Should I short NovoCure Ltd. stock?
-
NVCR Moving Average Covergence Divergence (MACD) indicator is -0.81, suggesting NovoCure Ltd. is a Sell
-
NovoCure Ltd. Relative Strength Index (RSI) is 31.55, which suggest NovoCure Ltd. is oversold
-
The Bollinger Bands (25) for NovoCure Ltd. is (11.24 - 14.16), which suggest NovoCure Ltd. is a Sell
-
The Bollinger Bands (100) for NovoCure Ltd. is (11.71 - 13.95), which suggest NovoCure Ltd. is a Sell
* NovoCure Ltd. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.